VivoSeq
Other

Randomized Controlled Trial

0

Pipeline Programs

45

Active Trials

5

Companies Involved

Randomized Controlled Trial is an early-stage landscape with 0 programs across 5 companies. The most active players are Jazz Pharmaceuticals, Portuguese Oncology Institute, Coimbra, AstraZeneca.

Pipeline Metrics

Competitive Density

47/100

Pipeline Velocity

45/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

212

clinical trials

Completed110 · 52%
Unknown status37 · 17%
Not yet recruiting20 · 9%
Terminated14 · 7%
Recruiting12 · 6%
Active, not recruiting12 · 6%
Other7 · 3%

Trial Activity

212 trials

Page 1 of 15

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)